These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18579327)

  • 21. Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.
    Panza F; Capurso C; D'Introno A; Colacicco AM; De Candia D; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2007 Jan; 55(1):133-5. PubMed ID: 17233704
    [No Abstract]   [Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of statin adverse effects in the elderly.
    Golomb BA
    Expert Opin Drug Saf; 2005 May; 4(3):389-97. PubMed ID: 15934847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke.
    Newman GC; Bang H; Hussain SI; Toole JF
    Neurology; 2007 Nov; 69(22):2054-62. PubMed ID: 18040011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive function in chronic kidney disease.
    Madero M; Gul A; Sarnak MJ
    Semin Dial; 2008; 21(1):29-37. PubMed ID: 18251955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin and cardiovascular disease: did the strongest statin hold the initial promises?
    Efthimiadis A
    Angiology; 2008; 59(2 Suppl):62S-4S. PubMed ID: 18628276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.
    Svilaas A; Strandberg T; Eriksson M; Hildebrandt P; Westheim A
    Scand Cardiovasc J; 2008 Aug; 42(4):279-87. PubMed ID: 18609053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of mild cognitive impairment for dementia. The influence of case definition and age.
    Baars MA; van Boxtel MP; Dijkstra JB; Visser PJ; van den Akker M; Verhey FR; Jolles J
    Dement Geriatr Cogn Disord; 2009; 27(2):173-81. PubMed ID: 19202336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.
    Faergeman O; Holme I; Fayyad R; Bhatia S; Grundy SM; Kastelein JJ; LaRosa JC; Larsen ML; Lindahl C; Olsson AG; Tikkanen MJ; Waters DD; Pedersen TR;
    Am J Cardiol; 2009 Aug; 104(4):459-63. PubMed ID: 19660594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.
    Xu G; Zhou Z; Zhu W; Fan X; Liu X
    J Neurol Sci; 2009 Sep; 284(1-2):77-80. PubMed ID: 19419739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
    Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
    Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P
    Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG; Zacho J
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are statin effects mediated through, or in spite of, their cholesterol-lowering action?
    Mascitelli L; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(2):262-3. PubMed ID: 19141486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.